$INSP
Inspire Medical Systems, Inc. Stock $insp

$insp Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000160955019000053 Filed on November 05, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$26.91M	$20.86M	$13.05M
YoY Change	62.49%	59.81%	79.54%
Cost Of Revenue	$4.240M	$3.456M	$2.467M
YoY Change	32.92%	40.09%	57.64%
Gross Profit	$22.67M	$17.41M	$10.59M
YoY Change	69.59%	64.41%	85.54%
Gross Profit Margin	84.25%	83.43%	81.1%
Selling, General & Admin	$28.19M	$22.43M	$24.78M
YoY Change	74.98%	-9.47%	202.93%
% of Gross Profit	124.37%	128.86%	234.03%
Research & Development	$3.770M	$3.623M	$1.771M
YoY Change	75.35%	104.57%	50.6%
% of Gross Profit	16.63%	20.81%	16.73%
Depreciation & Amortization	$160.0K	$130.0K	$100.0K
YoY Change	60.0%	30.0%	42.86%
% of Gross Profit	0.71%	0.75%	0.94%
Operating Expenses	$31.96M	$26.06M	$15.24M
YoY Change	74.93%	71.02%	62.86%
Operating Profit	-$9.293M	-$8.651M	-$4.649M
YoY Change	89.5%	86.08%	27.4%
Interest Expense	$250.0K	$529.0K	$680.0K
YoY Change	92.31%	-22.21%	58.88%
% of Operating Profit
Other Income/Expense, Net	$10.00K	$404.0K	-$44.00K
YoY Change	-200.0%	-1018.18%	-88.24%
Pretax Income	-$9.040M	-$8.247M	-$4.693M
YoY Change	89.12%	75.73%	16.65%
Income Tax	$40.00K	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$9.080M	-$8.247M	-$4.693M
YoY Change	90.04%	75.73%	16.68%
Net Earnings / Revenue	-33.75%	-39.53%	-35.95%
Basic Earnings Per Share
Diluted Earnings Per Share	-$377.1K	-$344.6K	-$219.6K
COMMON SHARES
Basic Shares Outstanding	24.06M shares	23.91M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$149.5M	$151.6M	$120.4M
YoY Change	-20.56%	25.91%
Cash & Equivalents	$22.86M	$48.04M	$26.31M
Short-Term Investments	$126.6M	$103.6M	$94.10M
Other Short-Term Assets	$2.200M	$3.200M	$1.000M
YoY Change	29.41%	220.0%
Inventory	$5.834M	$4.675M	$3.075M
Prepaid Expenses	$2.206M	$3.200M	$1.044M
Receivables	$13.13M	$10.99M	$5.410M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$170.6M	$170.5M	$130.0M
YoY Change	-14.37%	31.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.045M	$2.757M	$765.0K
YoY Change	279.68%	260.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.300M	$9.600M
YoY Change
Other Assets	$381.0K	$400.0K
YoY Change
Total Long-Term Assets	$10.62M	$12.76M	$765.0K
YoY Change	1223.82%	1568.37%
TOTAL ASSETS
Total Short-Term Assets	$170.6M	$170.5M	$130.0M
Total Long-Term Assets	$10.62M	$12.76M	$765.0K
Total Assets	$181.3M	$183.2M	$130.7M
YoY Change	-9.41%	40.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.500M	$4.800M	$2.400M
YoY Change	32.35%	100.0%
Accrued Expenses	$12.40M	$7.865M	$4.962M
YoY Change	60.46%	58.5%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$16.86M	$12.70M	$7.595M
YoY Change	51.11%	67.25%
LONG-TERM LIABILITIES
Long-Term Debt	$24.50M	$24.50M	$24.80M
YoY Change	-1.61%	-1.21%
Other Long-Term Liabilities	$40.00K		$0.00
YoY Change
Total Long-Term Liabilities	$24.56M	$24.50M	$24.81M
YoY Change	-1.46%	-1.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.86M	$12.70M	$7.595M
Total Long-Term Liabilities	$24.56M	$24.50M	$24.81M
Total Liabilities	$41.42M	$37.17M	$32.41M
YoY Change	14.79%	14.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$180.2M	-$171.1M	-$142.1M
YoY Change	22.63%	20.36%
Common Stock	$24.00K	$24.00K	$21.00K
YoY Change	4.35%	14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$139.8M	$146.1M	$98.31M
YoY Change
Total Liabilities & Shareholders Equity	$181.3M	$183.2M	$130.7M
YoY Change	-9.41%	40.17%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$9.080M	-$8.247M	-$4.693M
YoY Change	90.04%	75.73%	16.68%
Depreciation, Depletion And Amortization	$160.0K	$130.0K	$100.0K
YoY Change	60.0%	30.0%	42.86%
Cash From Operating Activities	-$6.080M	-$2.940M	-$3.560M
YoY Change	135.66%	-17.42%	14.1%
INVESTING ACTIVITIES
Capital Expenditures	-$440.0K	-$1.070M	$0.00
YoY Change	131.58%		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$19.55M	$560.0K	-$92.03M
YoY Change	-613.12%	-100.61%	1817.29%
Cash From Investing Activities	-$19.99M	-$500.0K	-$92.03M
YoY Change	-652.21%	-99.46%	1770.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	890.0K	190.0K	40.00K
YoY Change	-98.73%	375.0%	-50.0%
NET CHANGE
Cash From Operating Activities	-6.080M	-2.940M	-3.560M
Cash From Investing Activities	-19.99M	-500.0K	-92.03M
Cash From Financing Activities	890.0K	190.0K	40.00K
Net Change In Cash	-25.18M	-3.250M	-95.55M
YoY Change	-135.49%	-96.6%	1100.38%
FREE CASH FLOW
Cash From Operating Activities	-$6.080M	-$2.940M	-$3.560M
Capital Expenditures	-$440.0K	-$1.070M	$0.00
Free Cash Flow	-$5.640M	-$1.870M	-$3.560M
YoY Change	135.98%	-47.47%	18.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001609550
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2018Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1504
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38468
	dei	Entity Registrant Name EntityRegistrantName	Inspire Medical Systems, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1377674
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Trading Symbol TradingSymbol	INSP
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5500 Wayzata Blvd.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1600
	dei	Entity Address City Or Town EntityAddressCityOrTown	Golden Valley
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55416
	dei	City Area Code CityAreaCode	844
	dei	Local Phone Number LocalPhoneNumber	672-4357
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24062690	shares
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48044000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97288000	USD
CY2019Q3	us-gaap	Short Term Investments ShortTermInvestments	103558000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	90922000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10985000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6667000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	4675000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	2667000	USD
CY2019Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3200000	USD
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1734000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	170462000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	199278000	USD
CY2019Q3	us-gaap	Long Term Investments LongTermInvestments	9625000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2757000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	802000	USD
CY2019Q3	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	381000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7865000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55144000	USD
CY2018Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	0	USD
CY2019Q3	us-gaap	Assets Assets	183225000	USD
CY2018Q4	us-gaap	Assets Assets	200080000	USD
CY2019Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	4838000	USD
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3429000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7726000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12703000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11155000	USD
CY2019Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	24468000	USD
CY2018Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	24926000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	37171000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	36081000	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24038369	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24038369	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23401675	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23401675	shares
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	24000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	23000	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	317016000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	310941000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	90000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-52000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-171076000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-146913000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	146054000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	163999000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	183225000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	200080000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20862000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13054000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34034000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3456000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2467000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9404000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6863000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	17406000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	10587000	USD
	us-gaap	Gross Profit GrossProfit	45740000	USD
	us-gaap	Gross Profit GrossProfit	27171000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3623000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1771000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9072000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5236000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22434000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13465000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	62272000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	37416000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	26057000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	15236000	USD
	us-gaap	Operating Expenses OperatingExpenses	71344000	USD
	us-gaap	Operating Expenses OperatingExpenses	42652000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8651000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4649000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25604000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15481000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	903000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	641000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3025000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1049000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	529000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	680000	USD
	us-gaap	Interest Expense InterestExpense	1589000	USD
	us-gaap	Interest Expense InterestExpense	2615000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	404000	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-44000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1441000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1569000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8247000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4693000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24163000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17050000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-8247000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	-4693000	USD
	us-gaap	Profit Loss ProfitLoss	-24163000	USD
	us-gaap	Profit Loss ProfitLoss	-17050000	USD
CY2019Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	39000	USD
CY2018Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-26000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	142000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-26000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8208000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4719000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24021000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17076000	USD
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.02
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.40
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23940430	shares
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	21361739	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23713705	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12137512	shares
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	152489000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	191000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	58000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1524000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	39000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-8247000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	146054000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	163999000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	961000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	174000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	637000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4304000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	142000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24163000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	146054000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	102575000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	46000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	372000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-26000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-4693000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	98311000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1327000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	432000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
	insp	Stock Issued During Period Value Conversion Of Warrants StockIssuedDuringPeriodValueConversionOfWarrants	855000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	696000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-26000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17050000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	98311000	USD
	us-gaap	Profit Loss ProfitLoss	-24163000	USD
	us-gaap	Profit Loss ProfitLoss	-17050000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	342000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	288000	USD
	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	846000	USD
	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	214000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	456000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4304000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	696000	USD
	insp	Sharebased Compensation Noncash Services SharebasedCompensationNoncashServices	174000	USD
	insp	Sharebased Compensation Noncash Services SharebasedCompensationNoncashServices	37000	USD
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	USD
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-595000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	143000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4378000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1552000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2008000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-595000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1866000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	618000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1444000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-549000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	156000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	997000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26770000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16105000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2297000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	59000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	143524000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	98936000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	122254000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	11984000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23567000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-100000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-87011000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	8000000	USD
	insp	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	961000	USD
	insp	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	431000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	112042000	USD
	insp	Proceeds From Issuance Of Common Stock From Employee Stock Purchase Plan ProceedsFromIssuanceOfCommonStockFromEmployeeStockPurchasePlan	637000	USD
	insp	Proceeds From Issuance Of Common Stock From Employee Stock Purchase Plan ProceedsFromIssuanceOfCommonStockFromEmployeeStockPurchasePlan	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	531000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1067000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	120473000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-49244000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17357000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	USD
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	100000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97288000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8955000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48044000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26312000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1562000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1453000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	103000	USD
CY2018Q2	insp	Reclassification Of Warrant Liability To Additional Paid In Capital ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital	900000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the financial statements. We use significant judgment when making estimates related to the allowance for doubtful accounts, inventory reserves, warranty reserves, and the valuations of our common stock prior to our IPO, share-based awards, and certain of our previously outstanding preferred stock warrants. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div>
CY2018Q4	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0	USD
CY2018Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	USD
CY2018Q4	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0	USD
CY2018Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2019Q3	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2019Q3	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0	USD
CY2019Q3	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0	USD
CY2019Q3	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
CY2018Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:700;line-height:120%;">Concentration of Credit Risk</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash equivalents, investments, and accounts receivable. </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">Our investment policy limits investments to certain types of debt securities issued by the U.S. government and its agencies, corporations with investment-grade credit ratings, or commercial paper and money market funds issued by the highest quality financial and non-financial companies. We place restrictions on maturities and concentration by type and issuer. We are exposed to credit risk in the event of a default by the issuers of these securities to the extent recorded on the balance sheets. However, as of September 30, 2019 and December 31, 2018, we limited our credit risk associated with cash equivalents by placing investments with banks we believe are highly creditworthy.</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">We believe that the credit risk in our accounts receivable is mitigated by our credit evaluation process, relatively short collection terms, and dispersion of our customer base. We generally do not require collateral, and losses on accounts receivable have historically been within management's expectations.</span></div>
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	100000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	100000	USD
CY2019Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	800000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q3	us-gaap	Advertising Expense AdvertisingExpense	4700000	USD
CY2018Q3	us-gaap	Advertising Expense AdvertisingExpense	2300000	USD
	us-gaap	Advertising Expense AdvertisingExpense	12600000	USD
	us-gaap	Advertising Expense AdvertisingExpense	7000000.0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1395000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	802000	USD
CY2019Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3280000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1865000	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	4675000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	2667000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3608000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1601000	USD
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	851000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	799000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2757000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	802000	USD
CY2019Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100000	USD
CY2018Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	300000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	300000	USD
CY2019Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6999000	USD
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6490000	USD
CY2019Q3	us-gaap	Interest Payable Current InterestPayableCurrent	155000	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	195000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	711000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1041000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7865000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7726000	USD
CY2019Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	9188000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	12250000	USD
CY2019Q3	insp	Longterm Debt Maturities Repayments Of Principal Thereafter LongtermDebtMaturitiesRepaymentsOfPrincipalThereafter	3062000	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	24500000	USD
CY2019Q3	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P5Y
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	260000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1026000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	888000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1504000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2043000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	9448000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	15169000	USD
CY2019Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000	USD
CY2018Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	100000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	800000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	100000	USD
CY2018Q2	insp	Reclassification Of Warrant Liability To Additional Paid In Capital ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital	900000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2745156	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.64
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	81453000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	243037	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	60.37
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	610268	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.57
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	39577	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	34.31
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2338348	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M6D
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	96339000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1077235	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.18
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	61228000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1524000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	372000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4304000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	696000	USD
CY2019Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	18000000.0	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y9M18D
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20862000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13054000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55144000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34034000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2338348	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2279014	shares

Files In Submission

Name	View Source	Status
0001609550-19-000053-index-headers.html	Edgar Link	pending
0001609550-19-000053-index.html	Edgar Link	pending
0001609550-19-000053.txt	Edgar Link	pending
0001609550-19-000053-xbrl.zip	Edgar Link	pending
a2019-q3ex31x1.htm	Edgar Link	pending
a2019-q3ex31x2.htm	Edgar Link	pending
a2019-q3ex32x1.htm	Edgar Link	pending
a2019-q3ex32x2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
insp-20190930.htm	Edgar Link	pending
insp-20190930.xsd	Edgar Link	pending
insp-20190930_cal.xml	Edgar Link	unprocessable
insp-20190930_def.xml	Edgar Link	unprocessable
insp-20190930_g1.jpg	Edgar Link	pending
insp-20190930_htm.xml	Edgar Link	completed
insp-20190930_lab.xml	Edgar Link	unprocessable
insp-20190930_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INSP
Inspire Medical Systems, Inc. Stock $insp

2019 Q4 Form 10-Q Financial Statement

#000160955019000053 Filed on November 05, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSP Inspire Medical Systems, Inc. Stock $insp

2019 Q4 Form 10-Q Financial Statement

#000160955019000053 Filed on November 05, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSP
Inspire Medical Systems, Inc. Stock $insp